{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:34:09Z","timestamp":1778600049236,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1067\/mjd.2002.127249","type":"journal-article","created":{"date-parts":[[2003,5,28]],"date-time":"2003-05-28T03:08:28Z","timestamp":1054091308000},"page":"548-552","source":"Crossref","is-referenced-by-count":119,"title":["Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children"],"prefix":"10.1067","volume":"47","author":[{"given":"Payam","family":"Tristani-Firouzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta J.","family":"Petersena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Saffle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Zone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.127249_bib1","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.127249_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0733-8635(05)70196-0","article-title":"Toxic epidermal necrolysis","volume":"18","author":"Wolkenstein","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2002.127249_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/000992288902800904","article-title":"Toxic epidermal necrolysis. A comprehensive approach. Multidisciplinary management in a burn center","volume":"28","author":"Taylor","year":"1989","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1067\/mjd.2002.127249_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004630-199601000-00008","article-title":"Experience with toxic epidermal necrolysis treated in a burn center","volume":"17","author":"Yarbrough","year":"1996","journal-title":"J Burn Care Rehabil"},{"key":"10.1067\/mjd.2002.127249_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Arevalo","year":"2000","journal-title":"J Trauma"},{"key":"10.1067\/mjd.2002.127249_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000018112","article-title":"Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis?","volume":"198","author":"Paquet","year":"1999","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2002.127249_bib7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.127249_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(99)70497-4","article-title":"Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis","volume":"40","author":"Egan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.1985.01660120074023","article-title":"Plasmapheresis in severe drug-induced toxic epidermal necrolysis","volume":"121","author":"Kamanabroo","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"key":"10.1067\/mjd.2002.127249_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0305-4179(98)00191-0","article-title":"Treatment issues in the care of patients with toxic epidermal necrolysis","volume":"25","author":"Smoot","year":"1999","journal-title":"Burns"},{"key":"10.1067\/mjd.2002.127249_bib12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.127249_bib13","first-page":"29","article-title":"High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels","volume":"10","author":"Gottfried","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.127249_bib15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1067\/mjd.2001.112325","article-title":"High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin","volume":"44","author":"Rutter","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"iard","year":"1998","journal-title":"Science"},{"key":"10.1067\/mjd.2002.127249_bib17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0091-6749(96)80199-0","article-title":"Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS","volume":"98","author":"Sanwo","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2002.127249_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1440-0960.1999.00347.x","article-title":"Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin","volume":"40","author":"Phan","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2133.2000.03276.x","article-title":"A case of toxic epidermal necrolysis treated with intravenous immunoglobin","volume":"142","author":"Magina","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0733-8635(05)70193-5","article-title":"Intravenous immunoglobulin in autoimmune and inflammatory dermatoses. A review of proposed mechanisms of action and therapeutic applications","volume":"18","author":"Colsky","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2002.127249_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004630-199920060-00012","article-title":"Management of severe toxic epidermal necrolysis in children","volume":"20","author":"Sheridan","year":"1999","journal-title":"J Burn Care Rehabil"},{"key":"10.1067\/mjd.2002.127249_bib23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(89)80736-X","article-title":"Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"115","author":"Prendiville","year":"1989","journal-title":"J Pediatr"},{"key":"10.1067\/mjd.2002.127249_bib24","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0190-9622(85)70207-1","article-title":"Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases","volume":"13","author":"Ruiz-Maldonado","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.127249_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0140-6736(92)90806-E","article-title":"Effect of high-dose intravenous immunoglobulin therapy on blood rheology","volume":"339","author":"Reinhart","year":"1992","journal-title":"Lancet"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T01:54:09Z","timestamp":1553133249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0190962202000968"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.127249","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}